Seeking Alpha: $50 Million Plus Royalties Deal Indicates Bright Future For Oramed’s Oral Insulin December 22, 2015 In the News
Nasdaq: Oramed Unit, Genomma Lab Join To Commercialize Oral COVID-19 Vaccine Candidate In Mexico November 23, 2021 In the News
Oramed’s Success In Type 1 Diabetes Could Solve Novo Nordisk’s Problems November 11, 2013 In the News